383 related articles for article (PubMed ID: 19457058)
1. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
2. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
[TBL] [Abstract][Full Text] [Related]
3. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
De Vries R; Beusekamp BJ; Kerstens MN; Groen AK; Van Tol A; Dullaart RP
Scand J Clin Lab Invest; 2005; 65(8):729-37. PubMed ID: 16319046
[TBL] [Abstract][Full Text] [Related]
4. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
de Vries R; Groen AK; Perton FG; Dallinga-Thie GM; van Wijland MJ; Dikkeschei LD; Wolffenbuttel BH; van Tol A; Dullaart RP
Atherosclerosis; 2008 Feb; 196(2):733-41. PubMed ID: 17275009
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.
Dullaart RP; Groen AK; Dallinga-Thie GM; de Vries R; Sluiter WJ; van Tol A
Eur J Endocrinol; 2008 Jan; 158(1):53-60. PubMed ID: 18166817
[TBL] [Abstract][Full Text] [Related]
6. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.
Dullaart RP; Plomgaard P; de Vries R; Dahlbäck B; Nielsen LB
Clin Chim Acta; 2009 Aug; 406(1-2):129-33. PubMed ID: 19539616
[TBL] [Abstract][Full Text] [Related]
7. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
[TBL] [Abstract][Full Text] [Related]
8. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin is an important determinant of apoA-I catabolism.
Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M
Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
[TBL] [Abstract][Full Text] [Related]
13. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
Dallinga-Thie GM; van Tol A; Dullaart RP;
Biochim Biophys Acta; 2009 Aug; 1791(8):714-8. PubMed ID: 19303940
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C; Poy MN; Stoffel M
Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583
[TBL] [Abstract][Full Text] [Related]
15. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
[TBL] [Abstract][Full Text] [Related]
16. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
[TBL] [Abstract][Full Text] [Related]
17. Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus.
van Tienhoven-Wind LJ; Perton FG; Dullaart RP
Clin Biochem; 2016 Jan; 49(1-2):41-6. PubMed ID: 26320015
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
19. Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
Pan J; Shilian P; Ishida B; Wu X; Kane JP; Malloy MJ; Charles MA
Metabolism; 2011 Feb; 60(2):292-7. PubMed ID: 20303127
[TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.
Jiao GQ; Yuan ZX; Xue YS; Yang CJ; Lu CB; Lu ZQ; Xiao MD
Clin Biochem; 2007 Oct; 40(15):1108-12. PubMed ID: 17674965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
